東北大学

東北大学大学院医学系研究科
腎臓内科学分野
東北大学病院　腎臓・高血圧内科

論文・著書

～歴史ある論文・著書～

2008年

論文【英文】

  1. Mori K, Yoshida K, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S: Effects of angiotensin 2 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice; Clinical Immunology 126; 97-103, 2008
  2. Tanemoto M, Abe T, Ito S: Diagnosis of aldosterone producing adenomas; Kidney Int 73; 362-363, 2008
  3. Morimoto R, Satoh F, Murakami O, Suzuki T, Abe T, Tanemoto M, Abe M, Uruno A, Ishidoya S, Arai Y, Takahashi K, Sasano H, Ito S: Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas; Endocr J 55(1): 49-55, 2008
  4. Ozaki H, Mori K, Nakagawa Y, Hoshikawa S, Ito S, Yoshida K: Autonomously functioning thyroid nodule associated with thyrotoxic periodic paralysis; Endocr J; 55(1):113-119, 2008
  5. Ogawa S, Mori T, Nako K, Ishizuka T, Ito S: Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes; Clin J Am Soc Nephrol 3: 362-368, 2008
  6. Naritomi H, Fujita T, Ito S, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study; Hypertens Res 31: 295-304, 2008
  7. Tanemoto M, Toyohara T, Abe T, Ito S: MAGI-1a Functions as a Scaffolding Protein for the Distal Renal Tubular Basolateral K+ Channels; J Biol Chem 283(18): 12241-12247, 2008
  8. Tanemoto M, Uruno A, Abe T, Ito S: Hypocalcemia in a patient with severe hypertension and surgically induced relative hypoparathyroidism; J Bone Miner Metab 26: 298-300, 2008
  9. Nakayama M, Nakayama K, Zhu WJ, Shirota Y, Terawaki H, Sato T, Kohno　M, Ito S: Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: a possible pathological role for enhanced oxidative stress in chronic kidney disease; Nephrol Dial Transplant 23(10); 3096-3102, 2008
  10. Shimamoto K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimada K, Tanaka H, Yoshiike N: Impact of Blood Pressure Control on Cardiovascular Events in 26,512 Japanese Hypertensive Patients: The Japan Hypertension Evaluation with AngiotensinⅡ Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study; Hypertens Res 31: 469-478, 2008
  11. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S, for the INNOVATION Study Group: Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of the incipient to overt: angiotensin 2 blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study; Hypertens Res 31: 657-664, 2008
  12. Tanemoto M, Abe M, Uruno A, Abe T, Ito S: Angiographic index for angioplasty-treatable atheromatous renal artery stenosis; Hypertens Res 31: 881-885, 2008
  13. Ogawa S, Mori T, Nako K, Ito S: Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy; Hypertens Res 31: 1147-1155, 2008
  14. Nishiyama A, Nakagawa T, Kobori H, Nagai Y, Okada N, Konishi Y, Morikawa T, Okumura M, Meda I, Kiyomoto H, Hosomi N, Mori T, Ito S, Imanishi M: Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria; J Hypertens 26; 1849-1859, 2008
  15. Yamashita K, Okuyama M, Nakagawa R, Honma S, Satoh F, Morimoto R, Ito S, Takahashi M, Numazawa M: Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids; J Chromatogr A 1200; 114-121, 2008
  16. Morimoto R, Satoh F, Murakami O, Hirose T, Totsune K, Imai Y, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K: Expression of adrenomedullin2/ intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues; J Endocrinol 198(1); 175-183, 2008
  17. Kasai S, Inui M, Nakamura K, Kakizaki Y, Endo S, Nakamura A, Ito S, Takai T: A novel regulatory role of gp49B on dendritic cells in T-cell priming; Eur J Immunol 38; 2426-2437, 2008
  18. Izuhara Y, Sada T, Yanagisawa H, Koike H, Ohtomo S, Dan T, Ito S, Nangaku M, Strihou CY, Miyata T: A novel sartan derivative with very low angiotensin Ⅱ　type 1 receptor affinity protects the kidney in type 2 diabetic rats; Arterioscler Thromb Vasc Biol 28(10); 1767-1773, 2008
  19. Morimoto R, Satoh F, Murakami O, Totsune K, Saruta M, Suzuki T, Sasano H, Ito S, Takahashi K: Expression of peptide YY in human brain and pituitary tissues; Nutrition 24(9); 878-884, 2008
  20. Nakayama K, Nakayama M, Iwabuchi M, Terawaki H, Sato T, Kohno M, Ito S: Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients; Am J Nephrol 28(6): 871-878, 2008
  21. Uruno A, Sugawara A, Kudo M, Satoh F, Saito A, Ito S: Stimulatory effects of low-dose 3-Hydroxy-3-Methylglutaryl Coenzyme A reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activates protein kinase; Hypertens Res 31; 2085-2096, 2008
  22. Ohtomo S, Nangaku M, Izuhara Y, Yamada N, Dan T, Mori T, Ito S, Strihou CY, Miyata T: The role of megsin, a serin protease inhibitor, in diabetic mesangial matrix accumulation; Kidney Int 74; 768-774, 2008
  23. Shimada K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimamoto K, Tanaka H, Yoshiike N: The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study; Hypertens Res 31(10):1903-1911, 2008
  24. Suzuki T, Abe T: Thyroid hormone transporters in the brain; Cerebellum. 7(1):75-83.2008
  25. Okabe M., Szakács G., Reimers M.A., Suzuki T., Hall M.D., Abe T., Weinstein J.N. and Gottesman M.M.: Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters; Mol. Cancer. Ther. 7: 3081-3091, 2008
  26. Fukase K., Ohtsuka H., Onogawa T., Oshio H., Ii T., Mutoh M., Katayose Y., Rikiyama T., Oikawa M., Motoi F., Egawa S., Abe T. and Unno M: Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma; Cancer Sci.99:1785-1792, 2008
  27. Oshio H., Abe T., Onogawa T., Ohtsuka H., Sato T., Ii T., Fukase K., Muto M., Katayose Y., Oikawa M., Rikiyama T., Egawa S. and Unno M: Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines; J. Gastroenterol. 43: 538-549, 2008
  28. Yamaguchi H., Kobayashi. M, Okada M., Takeuchi T., Unno M., Abe T., Goto J., Hishinuma T. and Mano N: Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes; Cancer Lett. 260:163-169, 2008
  29. Ohguchi H, Tanaka T, Uchida A, Magoori K, Kudo H, Kim I, Daigo K, Sakakibara I, Okamura M, Harigae H, Sasaki T, Osborne TF, Gonzalez FJ, Hamakubo T, Kodama T, Sakai J: Hepatocyte nuclear factor 4 alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9; Mol Cell Biol. 2008 Jun;28(12):3917-31.
  30. Ohisa N, Yoshida K, Matsuki R, Suzuki H, Miura H, Ohisa Y, Murayama N, Kaku M, Sato H: A comparison of urinary albumin - total protein ratio to phase-contrast microscopic examination of urine sediment for differentiating glomerular and nonglomerular bleeding; Am J Kidney Dis, 52: 235-241, 2008
  31. Soma J, Tsuchiya Y, Sakuma T, Sato H: Clinical remission and histopathological resolution of nodular lesions in a patient with γ3 heavy chain deposition disease; Clin Nephrol, 69: 383-386, 2008
  32. Joh K, Taguchi T, Shigematsu H, Kobayashi Y, Sato H, Nishi S, Katafuchi R, Nomura S, Fujigaki Y, Utsunomiya Y, Sugiyama H, Saito T, Makino H: Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan; Clin Exp Nephrol, 12: 421-431, 2008
  33. Hirose T, Totsune K, Mori N, Morimoto R, Hashimoto M, Nakashige Y, Metoki H, Asayama K, Kikuya M, Ohkubo T, Hashimoto J, Sasano H, Kohzuki M, Takahashi K, Imai Y. Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure. Eur J Heart Fail. 2008 Sep;10(9):840-9
  34. Nakayama T, Hirose T, Totsune K, Mori N, Maruyama Y, Maejima T, Minagawa K, Morimoto R, Asayama K, Kikuya M, Ohkubo T, Hashimoto J, Kohzuki M, Takahashi K, Imai Y. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure. Peptides. 2008 May;29(5):801-8
  35. Matsuura T, Takase K, Ota H, Yamada T, Sato A, Satoh F, Takahashi S. Radiologic anatomy of the right adrenal vein: preliminary experience with MDCT. Am J Roentgenol. 2008; 191(2):402-8.
  36. Morimoto R, Satoh F, Murakami O, Totsune K, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K.Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues. Peptides. 2008; 29(5):873-80.
  37. Yoshida M, Shimizu N, Suzuki M, Watanabe C, Satoh M, Mori K, Yasutake A: Emergence of methylmercury toxicity long after a perinatal exposure in metallothionein-null and its wild-type C57BL mice strains; Environmental Health Perspectives 116; 746-751, 2008

論文【邦文】

  1. 杉浦章、伊藤貞嘉：特集/最新の高血圧治療の進歩　降圧薬の特性と使い方　ACE阻害薬；臨牀と研究85(1)；29－33,2008
  2. 伊藤貞嘉：特集/2007ヨーロッパ高血圧ガイドラインとJSH2004改訂に向けて　合併症を伴う高血圧治療‐腎臓；血圧15(1)；51－55,2008
  3. 森建文、伊藤貞嘉：CKDの合併随伴症候群　なぜ心・血管合併症をきたしやすいのか；Medical Practice25(2)；266－270,2008
  4. 細谷拓真、森建文、伊藤貞嘉：慢性腎臓病を合併した高血圧の特徴と血圧管理；Current Therapy26(2)；155－161，2008
  5. 伊藤貞嘉：18利尿薬；治療薬UP-TO-DATE2008；メディカルレビュー社；松澤祐次、永井良三、奥村勝彦編集；208－210,2008
  6. 伊藤貞嘉：特集　腎障害と心疾患－心腎相関を識る－　企画にあたって；Heart View 12(3)；230－231,2008
  7. 伊藤貞嘉：特集　腎障害と心疾患－心腎相関を識る－　心腎連関；Heart View 12(3); 232-236,2008
  8. 伊藤貞嘉：特集　腎障害と心疾患－心腎相関を識る－　利尿薬抵抗性とその対策；Heart View 12(3); 317-322, 2008
  9. 伊藤貞嘉：心腎連関研究の課題；循環器科63(2)；182－187,2008
  10. 伊藤貞嘉：メタボリックシンドロームの落とし穴：進化の宿命～宮城県は世界一～；宮城県医師会報747；215－219,2008
  11. 伊藤貞嘉：特集　腎と高血圧－最近の話題　高血圧による臓器障害に対する治療戦略；腎臓30(3)；269－274,2008
  12. 伊藤貞嘉：腎機能と高血圧；腎と高血圧シリーズ１；2008
  13. 伊藤貞嘉：血管イベントの危険因子としてのアルブミン尿と蛋白尿の意義；血圧15（４）；326－330，2008
  14. 菅原明、伊藤貞嘉：特集　副腎不全：診断と治療の進歩　Ⅱ．原発性副腎機能低下症の診断　３．Adrenoleukodystrophy;日本内科学会雑誌97(4)；732－735，2008
  15. 伊藤貞嘉：特集　CKDと降圧治療3　心腎連関のメカニズム；循環plus8(3)；2－6,2008
  16. 伊藤貞嘉：特集　腎疾患：診断と治療の進歩　Ⅲ．治療法の実際　1．降圧薬；日本内科学会雑誌97(5)；994-1001，2008
  17. 中山恵輔、中山昌明、伊藤貞嘉：メチルグリオキサール；臨床高血圧14(1)；14－20，2008
  18. 伊藤貞嘉：INNOVATION；臨床高血圧14(1)；50－52，2008
  19. 森本玲、木村伯子、佐藤文俊、齋藤淳、田代晶代、沖隆、成瀬光栄、三浦幸雄、伊藤貞嘉：褐色細胞腫・ガングリオーマにおける血中chromogranin A測定の臨床的意義；医学のあゆみ Vol225;No.12,1281-1282,2008
  20. 中道崇、森　建文、伊藤貞嘉：心不全における腎機能障害発症の機序．HeartView 2008;12(3):60-63
  21. 小川 晋、森 建文、伊藤 貞嘉：糖尿病腎症の克服をめざして　３糖尿病性腎症管理における降圧療法の意義；糖尿病学の進歩2008；診断と治療社；日本糖尿病学会編；275-278，2008．9月
  22. 森　建文、伊藤貞嘉：心腎連関を識る. 伊藤貞嘉編. 第一章　心臓と腎臓の連関２．腎障害と心血管疾患, 「～進化の宿命～」文光堂2008
  23. 森　建文、伊藤貞嘉：CKDにおける酸化ストレスと炎症, 腎と透析2008　Vol.64　No.3
  24. 細谷拓真,森　建文,佐藤　博,伊藤貞嘉：腎疾患　微量アルブミン尿とメタボリックシンドローム　Adiposcience vol.5 No.3 Sep. 2008 243-251
  25. 森　建文、伊藤貞嘉：慢性腎臓病と心血管病の関連を探る－なぜ微量アルブミン尿は心血管病のリスクファクターか？ Vascular Medicine 2008;4(4):19-25
  26. 小川 晋、森 建文、伊藤 貞嘉：ACE阻害薬およびAⅡ受容体拮抗薬の腎保護作用のエビデンス；日本臨床66増刊号9；279－284，2008
  27. 石塚 恒夫、小川 晋、森 建文、奈古 一宏、伊藤 修、Michal Laniado-Schwartzman、伊藤 貞嘉：ヒトの培養血管内皮細胞においてCYP４Aによるアラキドン酸代謝物である20-HETEがNF-κB活性や炎症性サイトカインの産生を増大する；Therapeutic Research 29(11)；21－22，2008
  28. 森　建文、星　慈、三井栄子、長谷川洋子、太田美智、伊藤めぐみ、佐藤洋美、佐藤康子、大原秀一、飛田　渉：肥満学生における尿中アルブミン排泄および酸化ストレスマーカーの検討、平成19年度高等教育開発推進センター紀要
  29. 細谷　拓真，森　建文，米城　淑美，大崎　雄介，遠藤　聡，小川　晋，佐藤　博，伊藤　貞嘉：糖尿病を伴ったDahl食塩感受性ラットの腎障害に対するインスリンの影響. Therapeutic Research 2008, 29(11):1915-1916, 2008.
  30. 森　建文、陳　献廣、胡　春艶、大崎雄介、朱　万君、米城淑美、郭　琪、中道　崇、細谷拓真、長澤　将、井上英行、小川　晋、中山昌明、伊藤貞嘉：慢性腎臓病の進展に対するMethylglyoxalの影響. Therapeutic Research 2008, 29(11):1884-1886.
  31. 井上英行, 森 建文, 小川 晋, 奈古一宏, 石塚恒夫, 佐藤博, 伊藤貞嘉：糖尿病性腎症のMRI-T1強調画像における皮髄境界消失と脂質および炎症との関連. Therapeutic Research 2008, 29(11):1910-1912.
TOP